About half of all MRIs use a GBCA to enhance diagnostic imaging scans. In addition to monitoring severe kidney insufficiency, the dyes are used during MRIs that scan brain injuries, liver inflammation, circulatory disorders, and inflammatory joint disease. In 2017, the FDA put warnings on GBCA products that recommend people with adequately functioning kidneys should not stop having MRI scans using GBCA dyes, as no studies indicate GBCA is detrimental to these individuals. Additionally, a gadolinium contrast agent is not always necessary when performing MRI scans. Whether one is necessary is a topic to discuss with a physician.
This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.